Stay with us! The PHOENIX consortium met in Madrid at @CSIC to discuss the future of our project & the PHOENIX SEP. We're leaving this platform. Make sure to follow our news via PHOENIX OITB & PHOENIX SEP on LinkedIn. Or subscribe to our newsletter! phoenix-sep.com/contact/

Topas Therapeutics is focused on developing nanoparticle-based drug products to address areas of major unmet need, including autoimmune diseases. Watch our interview to learn how they used the services of PHOENIX-OITB guided by PHOENIX SEP: youtu.be/0LeKWzoV5H0?feature…

PHOENIX was represented last week in the stunning Kuppelsaal of TU Wien at the acib Mini-Symposium "Enhanced Sustainability in Pharma". PHOENIX services were presented in an overview of initiatives with ties to Austria, and we welcomed interested attendees to our booth.

This year we have 3 partners on Stanford's "Top 2% Scientists" list. Congrats to - Ivana Vinković Vrček (IMI), - Johannes Khinast (@RCPE ) for making the 2024 list, and - Jesus M de la Fuente (@CSIC) for making the "career-long" list of top-cited resesarchers! 🔬 🎉

A valuable day spent with the #NABIHEAL team in Barcelona: @Asphalion & IMI organized a workshop on regulatory frameworks for #medicaldevices containing #nanomaterials and for #nanomedicines. Thanks to all involved! 👏

Thrilled to have 2 partners together at #PODD2024 - Partnership Opportunities in Drug Delivery - in #Boston! Visit us at: @nanomoltech (Booth 48) and @MyBiotechGmbH (Booth 12) to learn about the PHOENIX-OITB services accessed via our single entry point, PHOENIX SEP.

Are you at #CPHIMilan this week? Visit PHOENIX partner @nanomoltech at stand 18C7, zone Pharma Machinery and Equipment, to learn more about PHOENIX services for #nanopharmaceutical development! Find out more about them via their video: youtu.be/EReESsGKRmU?si=NvV8…

Our upcoming webinar speakers represent our 5 service areas: - Physico-chemical characterization - In vitro characterization - In vivo characterization - Manufacturing - Regulatory support (Not pictured: speaker Johannes Khinast @RCPE ) Register now! phoenix-oitb.eu/satellite-ev…

The Agenda for our webinar is here! Register now to hear from our speakers about the services of the PHOENIX-OITB, and how they can benefit companies and researchers. #OITB #nanopharmaceuticals #nanomedicine #pharma #CMC #characterization #regulation #regulatorycompliance

*Important announcement: Satellite Event moved ONLINE!* Due to requests to expand our introductory event of the PHOENIX-OITB services to a wider audience, we have decided to move the event entirely online! ➡️Register here: lnkd.in/dg-sqtmV

We're introducing PHOENIX to the pharma industry and SMEs interested accessing services in #nanopharmaceutical development from a Single-Entry-Point! Join us in Graz 🇦🇹 on Friday, Sept 13th, 10am-1pm followed by a networking lunch. Register here: lnkd.in/dBYK-kbk

Lange Nacht der Forschung in 🇦🇹: In Linz, RECENDT explained non-destructive testing & measurement of food products or #nanoparticles. In Graz, @RCPE used muesli & candy to show features of #nanopharmaceutical production while @bionanonet let kids discover #nano in nature.

Thank you #IndTech2024 for having our scientific coordinator @NazendeGT present PHOENIX at the #OITB satellit event today in Namur🇧🇪 Great to network and share knowledge & experience with other Open Innovation Test Beds. PHOENIX Single Entry Point: phoenix-sep.com

Curious if the PHOENIX Open Call is right for you? Our interview with Scientific Coordinator @NazendeGT shows potential applicants the process for getting funded services in nanopharmaceutical development! phoenix-oitb.eu/phoenix-oitb… #h2020 #EUfunding #GMP

PHOENIX will be represented at #ETPN2024 by @susanne_resch of @bionanonet. Take advantage of the early bird deadline and learn more about #nanomedicine and our single entry point for #nanopharmaceutical innovation: PHOENIX SEP!

Less than 1 month to go! Apply by May 3rd to receive funded access to a broad range of services in nanopharmaceutical development! #H2020 #funding #OpenCall #Nanopharmaceuticals

PHOENIX OITB was well represented in the the latest @bionanonet QUARTERLY! Take a look here: issuu.com/bnn-bionanonet/doc… Don't forget to subscribe to get 4 issues a year to your inbox: mailchi.mp/986d2c1e28e1/bnn-…

At the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (#PBPWorldMeeting) in Vienna from 18-21 March, @susanne_resch of @bionanonet presented a poster for PHOENIX-OITB. The event attracted hundreds from industry and research in pharma.

Last month, @aetureli @MyBiotechGmbH traveled to Los Angeles to present PHOENIX at the Drug Delivery Summit. Great opportunity to gain insights into the US market and bring attention to European innovation, PHOENIX & our Single Entry Point for nanopharmaceutical development.

Yesterday the work package leaders of the PHOENIX OITB project met at the facilities of @MyBiotechGmbH in Überherrn, Germany with our project advisor and monitor for our M36 Review Meeting. We are grateful for the good questions, suggestions and constructive criticism.